ZGT -- Yale Formula
Research authors: None
Details
Download

Discrimination

Rows included 109
C-index 0.63 | 95% CI: 0.5268 - 0.7408 ROC
Brier score Not specified
Scaled Brier score Not specified

Classification plot

Not specified

Calibration

Regression coefficient 0.8
Intercept 0.18
Hosmer-Lemeshow GOF Not specified
 

Calibration plot

Histogram

Not specified

Decision curve

Not specified
Comparison
Original study population: 2930
Validation study population: 0

Categorical characteristics

Name Subset / Group Nr. of patients Validation P-Value
Race White 2518 Not available
Black 244
American Indian/Alaska Native 4
Other unspecified 4
Unknown 23
Age (y, median = 61) <50 198 Not available
50-59 1085
60-69 1327
70-79 316
80+ 4
Gleason score 6 and lower 1079 Not available
7 1431
8 210
9 205
10 5
Clinical stage T1c 2126 Not available
T2a 215
T2b/T2c 589
Preoperative prostate specific antigen 0-2.5 164 Not available
2.6-4.0 304
4.1-6.0 1076
6.1-10 900
10.1-25.9 486
Pathological stage Organ confined 1936 Not available
Extraprostatic extension 725
Seminal vesicle invasion 108
Lymph node involvement 136
pT4 25
Number of lymph nodes examined pathologogically 10-15 1868 Not available
16-20 575
21-30 392
31-56 95
Comments
Comment
Please enter a comment
Comments are visible to anyone

Model feedback

No feedback yet 1 Comment {{ comments.length }} Comments
On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
{{ comment.content }}
Evidencio v3.25 © 2015 - 2024 Evidencio. All Rights Reserved